Anti-doping Committee launched

The IMMAF board has established a committee for anti-doping with the task of enabling WADA compliance within a year’s time, thus ensuring that MMA is at par with other major international sports when it comes to anti-doping policies.

Battling performance enhancing substance abuse is crucial not only to ensure fair play but most importantly from a health and safety perspective. Chosen to chair the committee is Mr. Bertrand Amoussou, Vice President of the IMMAF and President of the French MMA Federation.

The IMMAF member federations have been asked to nominate candidates for election to the committee and upon completion of that process additional committee members will be presented.

The first order of business for the committee is to investigate implementation for WADA compliance within the member federations and implications on matters such as sanctioning of professional events and compliance with the national guidelines in each individual country. This process is estimated to take six months after which the IMMAF anti-doping policies and procedures will be developed and then sent to WADA for approval.

Responsibilities of the Anti-Doping Committee:

– Development and maintenance of IMMAF anti-doping policies and procedures, ensuring compliance with the WADA code

– Education of member federations and assistance in implementation of anti-doping policies and procedures

– Development of IMMAF anti-doping education and information programmes for all stakeholders

– Development and maintenance of the IMMAF doping control program including pre and post competition testing, result based testing, random testing and targeted testing.

– Establishment of criteria for and maintenance of the IMMAF Registered Testing Pool (RTP), identifying those who need provide their whereabouts.

– WADA and National anti-doping organization communication

Annual report on IMMAF anti-doping activities

For more information on WADA please visit  

Leave a Reply

Your email address will not be published. Required fields are marked *